Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

60%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

2(40.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(2)

Detailed Status

Completed3

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (40.0%)

N/A3 (60.0%)

Trials by Status

completed360%

terminated120%

withdrawn120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria

NCT00385372

Clinical Trials (5)

Showing 5 of 5 trials

NCT05389683Not Applicable

Effect of Personalized Elimination Diet on Food Sensitivity Related Symptoms

Completed

NCT01821898Phase 2

Eosinophilic Esophagitis Clinical Therapy Comparison Trial

Terminated

NCT01897090Not Applicable

A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease

Withdrawn

NCT00526903Phase 2

Recurrent Abdominal Pain in Children

Completed

NCT00385372Not Applicable

Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5